| Experimental Group |
erector spinae plane block |
20 mL of 0.25% bupivacaine will be administered between erector spinae muscle and transverse process after negative aspiration of blood, air, or cerebrospinal fluid for block performance and local anesthesia will be distributed cranially and caudally |
after induction of general anesthesia and the ESP block will be performed unilaterally at site of operation |
The patients in group (A) will be put in lateral position after induction of general anesthesia and the ESP block will be performed unilaterally after identification of the thoracic T4 and T5 transverse processes and the erector spinae muscle with the probe placed 2–3 cm lateral to the spine with a sagittal approach. A 22-gauge spinal needle will be inserted into the muscle deeply as the transverse processes and the erector spinae muscle will be identified. The needle will be directed craniocaudally, and 20 mL of 0.25% bupivacaine will be administered between erector spinae muscle and transverse process after negative aspiration of blood, air, or cerebrospinal fluid for block performance and local anesthesia will be distributed cranially and caudally |
30 |
|
| Control Group |
ultrasound guided serratus anterior plane block SPB |
20 ml of 0.25% bupivacaine will be injected superficial to the serratus anterior muscle |
after induction of general anesthesia and the serratus anterior plane block will be performed unilaterally |
The patients will remain in supine position after induction of general anesthesia and the US-SPB will be done with the ultrasound probe positioned longitudinally oblique just below the mid-clavicle. After identifying the second rib, the probe will be moved caudally and laterally (obliquely), towards the mid-axillary line to identify the 3rd , 4th and 5th ribs. Finally, the probe will be positioned with its cephalad end resting over the anterior axillary line and the caudad end will be over the posterior axillary line. The fascial plane between the serratus anterior muscle and latissimus dorsi muscle will be identified between the 4th and 5 th rib in the mid-axillary region. Under ultrasound guidance, a 22-gauge, spinal needle will be advanced in-plane to enter this fascial plane in the superoanterior to posteroinferior direction. Once the needle was in proper position, 20 ml of 0.25% bupivacaine will be injected superficial to the serratus anterior muscle. |
30 |
Active-Treatment of Control Group |